These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 10825354

  • 1. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls.
    Eisensehr I, Linke R, Noachtar S, Schwarz J, Gildehaus FJ, Tatsch K.
    Brain; 2000 Jun; 123 ( Pt 6)():1155-60. PubMed ID: 10825354
    [Abstract] [Full Text] [Related]

  • 2. Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease, and controls.
    Eisensehr I, Linke R, Tatsch K, Kharraz B, Gildehaus JF, Wetter CT, Trenkwalder C, Schwarz J, Noachtar S.
    Sleep; 2003 Aug 01; 26(5):507-12. PubMed ID: 12938802
    [Abstract] [Full Text] [Related]

  • 3. Striatal dopamine transporter binding assessed by [I-123]IPT and single photon emission computed tomography in patients with early Parkinson's disease: implications for a preclinical diagnosis.
    Schwarz J, Linke R, Kerner M, Mozley PD, Trenkwalder C, Gasser T, Tatsch K.
    Arch Neurol; 2000 Feb 01; 57(2):205-8. PubMed ID: 10681078
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. 123I-beta-CIT and 123I-IBZM-SPECT scanning in levodopa-naive Parkinson's disease.
    Wenning GK, Donnemiller E, Granata R, Riccabona G, Poewe W.
    Mov Disord; 1998 May 01; 13(3):438-45. PubMed ID: 9613734
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Imaging and quantitation of dopamine transporters with iodine-123-IPT in normal and Parkinson's disease subjects.
    Kim HJ, Im JH, Yang SO, Moon DH, Ryu JS, Bong JK, Nam KP, Cheon JH, Lee MC, Lee HK.
    J Nucl Med; 1997 Nov 01; 38(11):1703-11. PubMed ID: 9374337
    [Abstract] [Full Text] [Related]

  • 10. Alteration of the striatal dopaminergic system in human narcolepsy.
    Eisensehr I, Linke R, Tatsch K, von Lindeiner H, Kharraz B, Gildehaus FJ, Eberle R, Pollmacher T, Schuld A, Noachtar S.
    Neurology; 2003 Jun 10; 60(11):1817-9. PubMed ID: 12796537
    [Abstract] [Full Text] [Related]

  • 11. Striatal dopamine transporter binding in early to moderately advanced Parkinson's disease: monitoring of disease progression over 2 years.
    Chouker M, Tatsch K, Linke R, Pogarell O, Hahn K, Schwarz J.
    Nucl Med Commun; 2001 Jun 10; 22(6):721-5. PubMed ID: 11403185
    [Abstract] [Full Text] [Related]

  • 12. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.
    Booij J, Habraken JB, Bergmans P, Tissingh G, Winogrodzka A, Wolters EC, Janssen AG, Stoof JC, van Royen EA.
    J Nucl Med; 1998 Nov 10; 39(11):1879-84. PubMed ID: 9829575
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by [123I]FPCIT SPECT.
    Booij J, Hemelaar TG, Speelman JD, de Bruin K, Janssen AG, van Royen EA.
    J Nucl Med; 1999 May 10; 40(5):753-61. PubMed ID: 10319746
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Functional morphometry of the striatum in Parkinson's disease on three-dimensional surface display of 123I-beta-CIT SPECT data.
    Ichise M, Kim YJ, Erami SS, Ballinger JR, Vines D, Tanaka F, Lang AE.
    J Nucl Med; 1999 Apr 10; 40(4):530-8. PubMed ID: 10210210
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.
    Stiasny-Kolster K, Doerr Y, Möller JC, Höffken H, Behr TM, Oertel WH, Mayer G.
    Brain; 2005 Jan 10; 128(Pt 1):126-37. PubMed ID: 15548552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.